Prisca Havranek-Kosicek becomes cfo at DSM Pharmaceutical Products

Formerly director of finance and control of DSM Pharma Chemicals

Prisca Havranek-Kosicek, previously director of finance and control for the DSM Pharma Chemicals business unit of DSM Pharmaceutical Products, the pharmaceutical contract manufacturing and technology organisation of Royal DSM, has been appointed cfo of the entire business group.

Havranek-Kosicek has worked in business finance and control, investor relations and management for 14 years.

Prior to joining DSM, she held executive positions in financial control at Immofinanz, and was managing director of AUA Beteiligungen and Austrian Airlines’ vice president, corporate subsidiaries and investor relations.

You may also like

Manufacturing

dsm-firmenich initiates patent infringement action

dsm-firmenich asserts that Shengda’s production of a key biotin intermediate at its Anhui site is an unlawful use of patented technology
Manufacturing

DSM and Chromatic 3D Materials partner

The global science-based company active in health, nutrition and materials, has entered a partnership with the 3D-printer developer to introduce thermoset materials for 3D-printing of finished manufactured goods
Manufacturing

DSM Sinochem to boost manufacturing capacity at Dutch plant

Increased production will meet growing demand for sustainable antibiotics, helping tackle Antimicrobial Resistance
Manufacturing

DSM Sinochem Pharmaceuticals celebrates 15 years of green 7-ADCA production

Saving more than lives alone
Infection Control

DSM Sinochem Pharmaceuticals wins European Responsible Care Award for work in sustainable antibiotics

Sustainable Antibiotics programme is DSP’s own initiative to promote the responsible manufacturing and use of antibiotics
Manufacturing

Update on SafeBridge potent compound safety certification programme

The programme provides drug innovators with an independent assessment of a manufacturing company’s ability to safely produce potent APIs and drug products
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

The impact of API properties on product design

Different properties of active ingredients can affect formulation design and development decisions. Dr Anil Kane, Patheon, and Dr Kai Donsbach, DSM Fine Chemicals Austria, look at some of the key properties
Subscribe now